EUVIMEDDescubrir EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

The Boron–Neuron Connection: The Potential of Boron‐Containing Molecules for Treating Incurable Amyotrophic Lateral Sclerosis

Nitesh Sanghai iD, Billy Vuong iD, Muhammad Shaharyar K Afridi iD, Sasha Leggett iD, Hemin Roghzai iD, Geoffrey K Tranmer iD

ChemMedChem · 2026-11-12 · 21 (21)

DOI: 10.1002/cmdc.70554 ↗

At a glance

Übersichtsarbeit in ChemMedChem, published online on 2026-10-27. Written by Nitesh Sanghai and 5 co-authors. Institution: College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. Major MEDLINE topics: Amyotrophic Lateral Sclerosis, Neuroprotective Agents, Boron Compounds, Neurons. 239 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council of Canada (NSERC).

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Background

Boron (B), a group 13 metalloid, has emerged as a versatile element at the intersection of chemistry, biology, and medicine. Its electron‐deficient nature and ability to reversibly interconvert between trigonal planar ( sp 2 ) and tetrahedral ( sp 3 ) geometries enable dynamic covalent interactions with biological nucleophiles, making boron‐containing compounds (BCCs) attractive pharmacophores that selectively interact with reactive oxygen species (ROS) and are ROS‐responsive for therapeutic development. BCCs possess antioxidant, anti‐inflammatory, and metal‐chelating properties that make them attractive candidates for neurodegenerative diseases. Amyotrophic lateral sclerosis (ALS), a fatal and multifactorial motor neurodegenerative disorder, is characterized by oxidative stress, neuroinflammation, mitochondrial dysfunction, and metal dyshomeostasis, providing a strong rationale for exploring boron‐based therapeutics.

Methods

This review examines current literature on B chemistry, pharmacology, and translational applications, with emphasis on mechanisms relevant to ALS pathogenesis. This review focuses on ROS‐responsive B scaffolds, blood–brain barrier (BBB) permeability, neuroprotective mechanisms, hormonal modulation, metal chelation, and emerging preclinical evidence supporting boron‐based interventions.

Conclusions

BCCs represent a promising yet underexplored therapeutic platform for ALS and related neurodegenerative disorders. Their ROS‐responsive, redox‐modulating, and neuroprotective properties, combined with favorable CNS drug‐like pharmacokinetics, offer a mechanistically distinct approach to disease modification. Emerging preclinical evidence strongly supports further translational investigation.

Subjects

MeSH terms (MEDLINE)

Amyotrophic Lateral SclerosisNeuroprotective AgentsBoron CompoundsNeuronsBoronHumansReactive Oxygen SpeciesAnimalsBlood-Brain BarrierMolecular StructureOxidative Stress

Author keywords

amyotrophic lateral sclerosis (ALS)blood–brain barrier (BBB)boron (B)boron‐containing compounds (BCCs)neurodegenerationreactive oxygen species (ROS)

Substances

Reactive Oxygen SpeciesNeuroprotective AgentsBoron CompoundsBoron

Authors and institutions

  • College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

ORCID profiles: Nitesh Sanghai, Billy Vuong, Muhammad Shaharyar K Afridi, Sasha Leggett, Hemin Roghzai, Geoffrey K Tranmer

Funding

  • Canadian Institutes of Health Research (CIHR)
  • Natural Sciences and Engineering Research Council of Canada (NSERC)

Cite

APA

Sanghai, N., Vuong, B., Afridi, M. S. K., Leggett, S., Roghzai, H., & Tranmer, G. K. (2026). The Boron–Neuron Connection: The Potential of Boron‐Containing Molecules for Treating Incurable Amyotrophic Lateral Sclerosis. ChemMedChem, 21(21). https://doi.org/10.1002/cmdc.70554

Vancouver

Sanghai N, Vuong B, Afridi MSK, Leggett S, Roghzai H, Tranmer GK. The Boron–Neuron Connection: The Potential of Boron‐Containing Molecules for Treating Incurable Amyotrophic Lateral Sclerosis. ChemMedChem. 2026;21(21). doi:10.1002/cmdc.70554

BibTeX
@article{Sanghai2026,
  author = {Sanghai, Nitesh and Vuong, Billy and Afridi, Muhammad Shaharyar K and Leggett, Sasha and Roghzai, Hemin and Tranmer, Geoffrey K},
  title = {The Boron–Neuron Connection: The Potential of Boron‐Containing Molecules for Treating Incurable Amyotrophic Lateral Sclerosis},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {21},
  doi = {10.1002/cmdc.70554}
}
Start for free →